Back to search
FDAFDA · Food and drugs·Recall number D-1433-201

Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, C-II, (50 mcg/mL), 50 mL Single-dose Fliptop Vial, Rx only. Hospira, Inc., Lake Forest, IL 60045. NDC: 0409-9094-61.

Published July 23, 2014 · Recall initiated: June 27, 2014

Summary

FDA records drug Class II recall D-1433-201, published July 23, 2014 and initiated June 27, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 47,400 vials; Lot: Lot #: 39474DK, Expiry: 03/01/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing.

What to do

Voluntary: Firm initiated · Letter

Get an email if FENTANYL CITRATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FENTANYL CITRATE
Manufacturer
Hospira Inc.
Distributor
U.S. Nationwide
Lot
Lot #: 39474DK, Expiry: 03/01/2016.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, C-II, (50 mcg/mL), 50 mL Single-dose Fliptop Vial, Rx only. Hospira, Inc., Lake Forest, IL 60045. NDC: 0409-9094-61. recalled?

Yes. FDA published recall D-1433-201 on July 23, 2014. Reported hazard: Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FENTANYL CITRATE.